Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.
Cornelia M UlrichCaroline HimbertAndreana N HolowatyjStephen D HurstingPublished in: Nature reviews. Gastroenterology & hepatology (2019)
Obesity increases the risk of multiple gastrointestinal cancers and worsens disease outcomes. Conversely, strong inverse associations have emerged between physical activity and colon cancer and possibly other gastrointestinal malignancies. The effect of weight loss interventions - such as modifications of diet and/or physical activity or bariatric surgery - remains unclear in patients who are obese and have gastrointestinal cancer, although large clinical trials are underway. Human intervention studies have already shed light on potential mechanisms underlying the energy balance-cancer relationship, with preclinical models supporting emerging pathway effects. Central to interventions that reduce obesity or increase physical activity are pluripotent cancer-preventive effects (including reduced systemic and adipose tissue inflammation and angiogenesis, altered adipokine levels and improved insulin resistance) that directly interface with the hallmarks of cancer. Other mechanisms, such as DNA repair, oxidative stress and telomere length, immune function, effects on cancer stem cells and the microbiome, could also contribute to energy balance effects on gastrointestinal cancers. Although some mechanisms are well understood (for instance, systemic effects on inflammation and insulin signalling), other areas remain unclear. The current state of knowledge supports the need to better integrate mechanistic approaches with preclinical and human studies to develop effective, personalized diet and exercise interventions to reduce the burden of obesity on gastrointestinal cancer.
Keyphrases
- physical activity
- weight loss
- insulin resistance
- bariatric surgery
- papillary thyroid
- adipose tissue
- oxidative stress
- type diabetes
- metabolic syndrome
- squamous cell
- endothelial cells
- dna repair
- clinical trial
- roux en y gastric bypass
- randomized controlled trial
- gastric bypass
- obese patients
- body mass index
- dna damage
- healthcare
- stem cells
- skeletal muscle
- high fat diet
- newly diagnosed
- high fat diet induced
- depressive symptoms
- signaling pathway
- risk assessment
- body composition
- resistance training
- drug induced
- cell therapy
- induced apoptosis
- prognostic factors
- phase iii
- polycystic ovary syndrome
- diabetic rats
- endoplasmic reticulum stress